Relate
Sonata |
| |
|
Sonata is used to treat short-term difficulty in falling asleep. Sonata has been shown to decrease the time to sleep onset for up to 28 days in clinical studies. Sonata has not been shown to increase your total sleep time or decrease the number of times you wake up after falling asleep. In general, medications used to bring on sleep should only be used for 7- 10 days.
|
Insomnia is the perception or complaint of inadequate or poor-quality sleep because of one or more of the following: 1) difficulty falling asleep 2) waking up frequently during the night with difficulty returning to sleep 3) waking up too early in the morning unrefreshing sleep Insomnia is not defined by the number of hours of sleep a person gets or how long it takes to fall asleep. Individuals vary normally in their need for, and their satisfaction with, sleep. Insomnia may cause prob...
|
Zaleplon as related to Insomnia
- zaleplon - Sleep Disorders Including, Sleep Apnea, Narcolepsy ...
Learn about sleep disorders including, insomnia, snoring and nightmares. ... GENERIC NAME: zaleplon BRAND NAME: Sonata. DRUG CLASS AND MECHANISM: Zaleplon is a hypnotic (a ...
- Zaleplon - Wikipedia, the free encyclopedia
Zaleplon (marketed under the brand names Sonata and Starnoc ) is a sedative / hypnotic , mainly used for insomnia . It is a nonbenzodiazepine hypnotic from the pyrazolopyrimidine class. ...
Chemistry · Pharmacology · Elderly · Side-effects · Carcinogenicity
- TA77 Insomnia - newer hypnotic drugs: Information for the public
Zaleplon, zolpidem and zopiclone for insomnia Understanding NICE guidance - information for people with insomnia, their families and carers, and the public April 2004 National ...
- Zaleplon ( Sonata ) and insomnia
Zaleplon: a review of its use in the treatment of insomnia by Dooley M, Plosker GL. Adis International Limited, Mairangi Bay, Auckland, New Zealand.
- Zaleplon ( Sonata ) to treat insomnia : a risk-benefit assessment
Benefit-risk assessment of zaleplon in the treatment of insomnia by Barbera J, Shapiro C. Sleep Research Unit, University Health Network, TWH, Toronto, Ontario, Canada.
- APA MEETING: Zaleplon Effective Against Insomnia Without Residual ...
APA MEETING: Zaleplon Effective Against Insomnia Without Residual Effects WASHINGTON, DC -- May 17, 1999 -- Results from two new clinical trials show that Wyeth-Ayerst Laboratories ...
- Zaleplon
Zaleplon is a drug that is prescribed to treat short-term insomnia in those having trouble falling asleep. This eMedTV article provides general information on zaleplon and its uses ...
- Zaleplon (28:24.92) - 399031
Insomnia. Zaleplon is used in the short-term management of insomnia. 1 2 12 13 14 15 16 18 19 Zaleplon has been shown to decrease sleep latency with repeated use for periods up to 30 days in ...
- APA MEETING: Zaleplon Effective Against Insomnia Without Residual ...
To print: Select File and then Print from your browser's menu ----- Title: APA MEETING:
- MedlinePlus Drug Information: Zaleplon
Zaleplon is used for short-term treatment of insomnia to help you fall asleep. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more ...

Not Signed In -


